Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder [PDF]
Addiction Science & Clinical PracticeBackground Medications for opioid use disorder (MOUD) are among the best tools available to combat the opioid epidemic. Yet, use of MOUD among people with opioid use disorder (OUD) remains low.
Nicholas C. Cardamone +3 more
doaj +2 more sources
Medication for opioid use disorder service delivery in carceral facilities: update and summary report [PDF]
Health & JusticeThe opioid overdose crisis intersects critically with the criminal legal system where individuals with opioid use disorder (are significantly overrepresented.
Justin Berk +6 more
doaj +2 more sources
Retention of people who inject drugs enrolled in a ‘medications for opioid use disorder’ (MOUD) programme in Uganda [PDF]
Addiction Science & Clinical PracticeAbstract Background Injection Drug use is associated with increased HIV risk behaviour that may result in the transmission of HIV and poor access to HIV prevention and treatment. In 2020, Uganda introduced the ‘medication for opioid use disorder (MOUD) treatment’ for People who inject drugs (PWID).
Peter Mudiope +7 more
openaire +4 more sources
Perspectives of the Obstetric Care Environment for Pregnant Individuals Who Have an Opioid Use Disorder [PDF]
Women's Health ReportsObjective: To assess the specific barriers and facilitators for pregnant individuals who have an opioid use disorder (OUD) receiving perinatal care. Methods: We conducted key informant interviews with patients who received care from obstetric clinicians ...
Samantha Girasulo +8 more
doaj +2 more sources
Drug and Alcohol Dependence Reports, 2023 Opioid use disorder is prevalent among individuals who are incarcerated, yet medications for opioid use disorder (MOUD) are not widely available in United States jails and prisons. Negative staff attitudes across the criminal legal system may prevent MOUD from being provided.
Aly Pfaff +4 more
openaire +4 more sources
Prescribers’ satisfaction with delivering medications for opioid use disorder [PDF]
Substance Abuse Treatment, Prevention, and Policy, 2021 Background Expanding access to medications for opioid use disorder (MOUD), such as buprenorphine and extended release (XR) naltrexone, is critical to addressing the US opioid epidemic, but little is known about prescriber satisfaction with delivering ...
Hannah K. Knudsen +8 more
doaj +3 more sources
Patient perspectives of jail based MOUD treatment: views of individuals who have returned to the community following incarceration [PDF]
Health & JusticeBackground Massachusetts passed legislation in 2018 to mandate provision of medications for opioid use disorder (MOUD) in select jails to address the high risk of opioid overdose after release.
Claudia Santelices +6 more
doaj +2 more sources
Impact of recent stimulant use on treatment outcomes amongst individuals initiating medications for opioid use disorders: Secondary analysis of a multisite randomized controlled trial [PDF]
Drug and Alcohol Dependence ReportsIntroduction: Illicit stimulant use among individuals initiating medication for opioid use disorder (MOUD) has significantly increased over the past decade.
Cari Coles +7 more
doaj +2 more sources
Journal of Medical Internet ResearchBackgroundDiscontinuation of buprenorphine as a medication for opioid use disorder (MOUD) necessitates careful tapering to reduce opioid withdrawal and relapse.
Michael K Gilbert +5 more
doaj +2 more sources
Medications for opioid use disorder in traditional medicare beneficiaries: associations with age. [PDF]
Health Aff SchRates of opioid use disorder (OUD) have increased in older adults (age ≥ 50). Medications for OUD (MOUD) treat OUD effectively; however, limited data exist on whether older adults with OUD are provided MOUD.
Ganz DA +6 more
europepmc +3 more sources